SP
AGN

SWS Partners’s Allergan plc AGN Stock Holding History

SWS Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 426
2017
Q4 		$0 Buy
+2
New +$359 ﹤0.01% 409

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

SWS Partners's AGN Position: Q1 2018 in Review

SWS Partners sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2 shares.

SWS Partners first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • SWS Partners reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • SWS Partners sold 2 Allergan plc shares in Q1 2018.
  • SWS Partners first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
  • SWS Partners's Allergan plc position peaked at $0 in Q4 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on SWS Partners's 13F filing for Q1 2018, filed 15 May 2018.